Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis

Clinical and Experimental Immunology

Volumn 147, Issue 2, 2007, Pages 236-240

  Donaghy, L ^a,b   Gros, F ^b   Amiot, L ^b   Mary, C ^c   Maillard, A ^a   Guiguen, C ^a,b   Gangneux, J P ^a,b,d  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Inst de Med Légale   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d Inst de Medecine Legale de Rennes   (France)

Author keywords

HIV; HLA G; Leishmania donovani; Soluble HLA G; Visceral leishmaniasis

Indexed keywords

LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOMODULATION; LEISHMANIA INFANTUM; PRIORITY JOURNAL; SEROLOGY; STATISTICAL ANALYSIS; VISCERAL LEISHMANIASIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; LEISHMANIASIS, VISCERAL; SOLUBILITY;

EID: 33846251260     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03268.x     Document Type: Article

References (15)

1. Lopez-Botet M, Llano M, Navarro F, Bellon T. NK cell recognition of non-classical HLA class I molecules. Semin Immunol 2000; 12:109-19.
2. Le Friec G, Laupeze B, Fardel O et al. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol 2003; 64:752-61.
3. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 2001; 98:12150-5.
4. Rizzo R, Hviid TV, Stignani M et al. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005; 57:172-81.
5. Matte C, Lajoie J, Lacaille J, Zijenah LS, Ward BJ, Roger M. Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. Aids 2004; 18:427-31.
6. Lozano JM, Gonzalez R, Kindelan JM et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. Aids 2002; 16:347-51.
7. Wilson ME, Jeronimo SM, Pearson RD. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog 2005; 38:147-60.
8. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 2003; 97 (Suppl. 1):3-15.
9. Derrien M, Pizzato N, Dolcini G et al. Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. J Gen Virol 2004; 85:1945-54.
10. Sebti Y, Le Friec G, Pangault C et al. Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol 2003; 64:1093-101.
11. Cabello A, Rivero A, Garcia MJ et al. HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Hum Immunol 2003; 64:1045-9.
12. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001; 22:553-5.
13. Wolday D, Berhe N, Akuffo H, Britton S. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today 1999; 15:182-7.
14. Korbel DS, Finney OC, Riley EM. Natural killer cells and innate immunity to protozoan pathogens. Int J Parasitol 2004; 34:1517-28.
15. Wolday D, Berhe N, Britton S, Akuffo H. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. Aids 2000; 14:921-9.